The successful applicant will work in collaboration with other post-doctoral researchers and technicians in the School of Pharmacy and the School of Veterinary Medicine, to develop a single-dose DNA vaccine against Zika virus. They will assist with the cloning of vaccine constructs and focus on facilitating the measuring of antibody and T-cell responses to the vaccines. They will also contribute to writing research papers and new grants to support continued research within the BDI and WCGVR. They will also interact with Brazilian collaborators on this project.
Candidates should have, or be close to completion of a PhD in a discipline relevant to research area. Experience in conducting ELISAs, virus neutralising antibody tests and measuring T-cell responses (IFNy ELISpot) is desirable. The candidate will be required to undertake research and day to day management of design, construct and test aspects of this research project, requiring a high degree of competence in the research area. An aptitude for critical thinking and a flexible approach to collaborative research is vital.